Skip to main content
Veterinary Medicines

PARACOX-5, SUSPENSION FOR ORAL SUSPENSION FOR CHICKENS

Authorised
  • Eimeria acervulina, strain HP, Live
  • Carminic acid
  • Eimeria maxima, strain CP, Live
  • Eimeria tenella, strain HP, Live
  • Eimeria mitis, strain HP, Live
  • Eimeria maxima, strain MFP, Live

Product identification

Medicine name:
PARACOX-5, SUSPENSION FOR ORAL SUSPENSION FOR CHICKENS
Paracox-5, Suspension zur Herstellung einer oralen Suspension für Hühner
Active substance:
  • Eimeria acervulina, strain HP, Live
  • Carminic acid
  • Eimeria maxima, strain CP, Live
  • Eimeria tenella, strain HP, Live
  • Eimeria mitis, strain HP, Live
  • Eimeria maxima, strain MFP, Live
Target species:
  • Chicken (broiler)
  • Chicken (one day-old chick)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Eimeria acervulina, strain HP, Live
    500.00
    Organisms
    /
    1.00
    Dose
  • Carminic acid
    0.10
    millilitre(s)
    /
    1.00
    Dose
  • Eimeria maxima, strain CP, Live
    500.00
    Organisms
    /
    1.00
    Dose
  • Eimeria tenella, strain HP, Live
    1000.00
    Organisms
    /
    1.00
    Dose
  • Eimeria mitis, strain HP, Live
    100.00
    Organisms
    /
    1.00
    Dose
  • Eimeria maxima, strain MFP, Live
    200.00
    Organisms
    /
    1.00
    Dose
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Chicken (broiler)
      • All relevant tissues
        0
        day
    • Chicken (one day-old chick)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AN01
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Merck Sharp & Dohme Animal Health S.L.
  • MSD Animal Health UK Limited
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.01272.01.1
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0351/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 1/02/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 1/02/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."